Rebalancing the Fat Content of the Heart and Muscles

Inclusion Criteria: * Patients with a confirmed diagnosis of type 2 diabetes established in the previous 10 years between the ages of 20 and 75 * HbA1c ≥ 53 mmol/mol (7%) typically on diet and/or metformin/sulphonylureas (and/or sodium-glucose cotransporter-2 inhibitors, Dipeptidyl peptidase 4 inhibitors, thiazolidinediones, but not on insulin) * Patients who do not meet the WHO recommendations on physical activity (≤150 minutes per week) of moderate-vigorous physical activity (MVPA) * Patients who have a BMI of ≥27 but with a body weight of less than 140kgs due to limitations of the scanner table weight limit * Current or recent (within 3 months) eGFR \>30 mL/min/1.73m2) * Able to understand written and spoken English Exclusion Criteria: * Any previously unknown cardiac condition other than mild valvular disease * Any history of known coronary artery disease (including myocardial infarction and myocardial infarction with normal coronary arteries) * Any relevant or untreated endocrine condition (i.e. Cushings) * Impaired renal function (defined as estimated glomerular filtration rate of less than 30 mL/min/1.73m2) * Blood pressure of more than 180/100 mmHg * Patients on any other medication known to influence glucose or fatty acids metabolism (niacin, omega-3 fatty acids, other glucagon-like peptide-1 receptor agonists) * Patients with any dietary habits that may interfere with the investigation (for example high fat vegan diets, as we know form prior research that they ha…